Introduction：Basic information about CAS 135326-22-6|Gadoxetate disodium, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Gadoxetate disodium |
|---|
| CAS Number | 135326-22-6 | Molecular Weight | 730.751220000001 |
|---|
| Density | / | Boiling Point | / |
|---|
| Molecular Formula | C23H28GdN3Na2O11 | Melting Point | / |
|---|
| MSDS | / | Flash Point | / |
|---|
Names
| Name | Gadoxetate Disodium |
|---|
| Synonym | More Synonyms |
|---|
Gadoxetate disodium BiologicalActivity
| Description | Gadoxetate Disodium (Gd-EOB-DTPA Disodium; ZK 139834) is a contrast agent in magnetic resonance imaging (MRI) of the hepatobiliary system, which accumulates in normal, functioning hepatocytes. Gadoxetate Disodium (Gd-EOB-DTPA Disodium; ZK 139834) is used to evaluate focal liver lesions, such as hepatocellular carcinoma or liver metastasis on T1-weighted imaging[1][2][3]. |
|---|
| Related Catalog | Research Areas >>CancerSignaling Pathways >>Others >>Others |
|---|
| References | [1]. Schuhmann-Giampieri G, et al. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology. 1992 Apr;183(1):59-64. [2]. Katsube T, et al. Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging. Invest Radiol. 2011 Apr;46(4):277-83. [3]. Saito K, et al. Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase. Magn Reson Med Sci. 2005;4(1):1-9. |
|---|
Chemical & Physical Properties
| Molecular Formula | C23H28GdN3Na2O11 |
|---|
| Molecular Weight | 730.751220000001 |
|---|
| InChIKey | SLYTULCOCGSBBJ-UHFFFAOYSA-I |
|---|
| SMILES | CCOc1ccc(CC(CN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-])cc1.[Gd+3].[Na+].[Na+] |
|---|
Synonyms
